Accession Number: | 0001209191-19-058938 |
Date: | 2019-12-02 |
Issuer: | ACORDA THERAPEUTICS INC (ACOR) |
Original Submission Date: |
SABELLA LAUREN M
420 SAW MILL RIVER ROAD
ARDSLEY, NY 10502
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-12-02 | S | 1,513 | d | $1.60 | 12,624 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | sales pursuant to a 10b5-1 plan. these sales are primarily intended to cover the tax liability resulting from restricted stock vesting. |
f2 | the price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $1.53 to $1.68 per share. the reporting person will provide to the issuer, any security holder of the issuer or the sec staff, upon request, information regarding the number of shares sold at each price within the range. |